# Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers

> **NCT03938597** · — · UNKNOWN · sponsor: **The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)** · enrollment: 10 (estimated)

## Conditions studied

- Drug-Related Side Effects and Adverse Reactions

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03938597
- **Lead sponsor:** The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-30
- **Primary completion:** 2023-06
- **Final completion:** 2023-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03938597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03938597, "Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03938597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*